Quality Outcomes Indicators definition

Quality Outcomes Indicators means the agreed key performance indicators and outcomes to be achieved as set out in Section 5 of the Order Form or Framework Schedules 7 or 9;
Sample 1Sample 2Sample 3
Quality Outcomes Indicators means the agreed milestones, currency indicators, performance indicators and outcomes to be achieved as set out in sections 7, 8 and 9 of the individual service specifications
Sample 1Sample 2Sample 3
Quality Outcomes Indicators means the agreed milestones, currency indicators, performance indicators and outcomes to be achieved as set out in sections 7, 8 and 9 of the individual service specifications Contract Management Meeting meansa meeting of the Authority and the Provider held in accordance with clause B29.8 (Contract Management) CQC Regulations means the Care Quality Commission (Registration) Regulation 2009 Currency means unit of output, activity or healthcare, which is paid for by commissioners. Each service has a minimum Currency target to achieve each quarter/year.
Sample 1

Examples of Quality Outcomes Indicators in a sentence

  • B29.1. If the Parties have agreed a consequence in relation to the Provider failing to meet a Quality Outcomes Indicator as set out in Appendix C (Quality Outcomes Indicators) and the Provider fails to meet the Quality Outcomes Indicator, the Authority may exercise the agreed consequence immediately and without issuing a Contract Query, irrespective of any other rights the Authority may have under this clause B29.

  • If the Parties have agreed a consequence in relation to the Provider failing to meet a Quality Outcomes Indicator as set out in the Service Specifications and/or Appendix C (Quality Outcomes Indicators) and the Provider fails to meet the Quality Outcomes Indicator, the Authority may exercise the agreed consequence immediately and without issuing a Contract Query, irrespective of any other rights the Authority may have under this clause B30.

  • Large scale wind, solar, hydro, waste to energy projects have been built and operating cross-country.

  • Quality Standards, Performance Measures 6.1.1 Quality Outcomes Indicators: Other than those set out above in section 5 there are no additional quality outcomes.

  • Appendix 1 Quality Outcomes Indicators The provider shall report Quality Outcomes Indicators in the Contract Review meetings (monthly or quarterly as appropriate) clearly indicating any variance from the thresholds indicated below (for example by indicating the threshold number or percentage in the body of the report alongside reported performance).

  • If the Parties have agreed a consequence in relation to the Provider failing to meet a Quality Outcomes Indicator as set out in Appendix B (Quality Outcomes Indicators) and the Provider fails to meet the Quality Outcomes Indicator, the Authority may exercise the agreed consequence immediately and without issuing a Contract Query, irrespective of any other rights the Authority may have under this clause 33.

  • If the Parties have agreed a consequence in relation to the Provider failing to meet a Quality Outcomes Indicator as set out in Appendix C (Quality Outcomes Indicators) and the Provider fails to meet the Quality Outcomes Indicator, the Authority may exercise the agreed consequence immediately and without issuing a Contract Query, irrespective of any other rights the Authority may have under this clause B29..

  • Quality Outcomes Indicators figures/tables for Weight Management 2010 – 2013, which appear to have been omitted from the report.

  • Students are financially responsible for the damage, loss or theft of residence hall furniture.

  • Quality Outcomes Indicators) The pharmacy provides one to one support and advice to the user, and referral to own GP or telephone support if necessary.The pharmacy facilitates access to, and where appropriate supplies, appropriate stop smoking drugs and aids.


More Definitions of Quality Outcomes Indicators

Quality Outcomes Indicators means the agreed key performance indicators and outcomes to be achieved
Sample 1

Related to Quality Outcomes Indicators

  • Monitoring Indicator means a measure of HSP performance that may be monitored against provincial results or provincial targets, but for which no Performance Target is set;

  • MSAA Indicator Technical Specifications document means, as the context requires, either or both of the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Indicator Technical Specifications November 5, 2018 Version 1.3” and the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Target and Corridor-Setting Guidelines” as they may be amended or replaced from time to time;

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Direction-indicator lamp means the lamp used to indicate to other road-users that the driver intends to change direction to the right or to the left;

  • Phase III Clinical Trial means a large, controlled or uncontrolled Clinical Study that would satisfy the requirements of 21 CFR 312.21(c), intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling.

  • Product Conditions means these product terms and conditions. These Product Conditions apply to each series of cash settled Warrants over single equities;

  • Performance Indicators means the indicators for Project monitoring and evaluation set forth in the Operational Manual.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Drug test means a test designed to detect the illegal use of a controlled substance.